BackHeron Therapeutics Overview

Heron Therapeutics Total Revenue

Revenue analysis for HRTX.

Quarterly Revenue

$34.71M
10.78% YoY

As of Mar 2026

Annual Revenue (TTM)

$150.71M
4.6% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading